Go Back

MYNVAX PRIVATE LIMITED

Mynvax

U73200KA2017PTC102838

Get Comprehensive Report

₹1,999.00 ₹3,998.00
Suggest Edit Last updated: Jan 17, 2025
Key Metrics
  • No. of Employees17
  • Founded Year 2017
  • Company StagePrivate Limited Company
  • Total Funding₹73.99 Cr
  • Industry

  • Headquarter
  • Company StatusActive
About Mynvax
Mynvax is a pre-clinical stage vaccine biotechnology. Current develop programs include a recombinant vaccine for human influenza and COVID19.
Business Model

Indian-based biotech startup, Mynvax develops flu vaccines. Besides advancing its existing vaccine candidates in India and overseas, the company is also investing in new vaccine modalities.

Top Competitors
LY
LybrateU74140HR2014FTC052854
QU
Qure.aiU74999MH2016PTC283891
MO
MolbioU33125GA2000PTC002909
Mynvax Funding Details
Funding Highlights
Latest Funding RoundSeries A
Total Funding Raised₹73.99 Cr
No. of Investments Made0
Total No. of Acquisitions0
Lead Investors3
Investors
  • Accel, N Lakshmi Narayan, Kotak
Funding Details
TheKredible's detailed funding report contains info about Funding raised by the company along with Lead Investors, Investors, Shareholding Strcuture, and its Investments & Acquisitions.
₹799.00 ₹1,598.00
Funding History
TheKredible's 'Funding History' report provides deep insights of Funding with list of Lead Investors
₹399.00 ₹798.00
Funding Per Year
A Funding report of the company's overall funding on yearly basis, segregated by the team TheKredible.
₹199.00 ₹398.00
Mynvax Financial Details
Financial Highlights
FY 2023-24 Revenue₹2.81 Cr
FY 2023-24 Expenses₹12.24 Cr
FY 2023-24 Profit/Loss-₹9.42 Cr
Net Cash Flow From Operations-₹7.45 Cr
Full Financial Details
Detailed report containing info about Business Model, year-wise Financial Comparison, Ratio Analysis and detailed Revenue and Expense breakdowns.
₹799.00 ₹1,598.00
Financial Comparison
A detailed report of year-wise Financial Comparison of the company
₹430.00 ₹860.00
Revenue Breakdown
A report and breakdown of the company's year-wise revenue streams.
₹399.00 ₹798.00
Expense Breakdown
A report and breakdown of the company's year-wise expenditures.
₹399.00 ₹798.00
Shareholding Structure
Team at TheKredible has gone through several ROC filings and portrayed Shareholding Structure of the company.
₹499.00 ₹998.00
Financial Ratio
Analysis of Financial Ratios which gives quick insights about the company's profitability and capital efficiency.
₹199.00 ₹398.00
Mynvax Key People
People Metrics
Current Core Team2
Board Members/Directors6

Core Team

GN
Gautham NadigCo-Founder
RV
Raghavan VaradarajanCo-Founder

Board Members/Directors

GM
Ganesh Murthy KishoreDirector
GN
Gautham NadigDirector
AS
Arun Suresh ChandavarkarDirector
AG
Anil GudibandeDirector
RV
Raghavan VaradarajanDirector
MB
Mahendran BalachandranNominee Director
Mynvax Documents

AY - 2018-19

Profit and Loss statement - Mynvax - 2018-19.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Mynvax for FY 2018-19.
₹249.00 ₹498.00
Balance Sheet - Mynvax - 2018-19.pdf
TheKredible's experts has summarized the Balance Sheet of Mynvax for FY 2018-19.
₹249.00 ₹498.00

AY - 2019-20

Profit and Loss statement - Mynvax - 2019-20.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Mynvax for FY 2019-20.
₹249.00 ₹498.00
Balance Sheet - Mynvax - 2019-20.pdf
TheKredible's experts has summarized the Balance Sheet of Mynvax for FY 2019-20.
₹249.00 ₹498.00

AY - 2020-21

Profit and Loss statement - Mynvax - 2020-21.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Mynvax for FY 2020-21.
₹249.00 ₹498.00
Balance Sheet - Mynvax - 2020-21.pdf
TheKredible's experts has summarized the Balance Sheet of Mynvax for FY 2020-21.
₹249.00 ₹498.00

AY - 2021-22

Profit and Loss statement - Mynvax - 2021-22.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Mynvax for FY 2021-22.
₹249.00 ₹498.00
Balance Sheet - Mynvax - 2021-22.pdf
TheKredible's experts has summarized the Balance Sheet of Mynvax for FY 2021-22.
₹249.00 ₹498.00

AY - 2022-23

Profit and loss statement - Mynvax - 2022-23.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Mynvax for FY 2022-23
₹249.00 ₹498.00
Balance sheet - Mynvax - 2022-23.pdf
TheKredible's experts has summarized the Balance Sheet of Mynvax for FY 2022-23
₹249.00 ₹498.00

AY - 2023-24

Profit and loss statement - Mynvax - 2023-24.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Mynvax for FY 2023-24
₹249.00 ₹498.00
Balance sheet - Mynvax - 2023-24.pdf
TheKredible's experts has summarized the Balance Sheet of Mynvax for FY 2023-24
₹249.00 ₹498.00

Subscribe to our newsletter to stay updated

Weekly Funding Reports
Funding Report
Weekly Funding Report [28 Apr - 03 May, 2025]
Monthly Funding Reports
Funding Report
Indian startups' funding falls to $745 Mn in April

Get your Customised Report

With an exclusive 20% off on your order

Latest Industry Reports
Industry Report
HealthTech’s Rebound: After a Downturn, HealthTech...